Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells-Reference-Cited by-同舟云学术

Robust CRISPR-Cas9 Genetic Editing of Primary Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Cells

Published:2023-06 Issue:6 Volume:7 Page:e909
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Mateos-Jaimez Judith¹,Mangolini Maurizio²,Vidal Anna¹,Kulis Marta¹,Colomer Dolors¹³⁴⁵,Campo Elias¹³⁴⁵,Ringshausen Ingo²,Martin-Subero Jose I.¹³⁶,Maiques-Diaz Alba¹

Affiliation:

1. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

2. Department of Hematology and Cambridge Stem Cell Institute, University of Cambridge, United Kingdom

3. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

4. Hematopathology Unit, Pathology Department, Hospital Clinic, Barcelona, Spain

5. University of Barcelona, Spain

6. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

Publisher

Wiley

Subject

Hematology

Reference14 articles.

1. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions.;Puente;Blood,2018

2. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.;Nadeu;Blood,2020

3. Molecular map of chronic lymphocytic leukemia and its impact on outcome.;Knisbacher;Nat Genet,2022

4. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.;Bichi;Proc Natl Acad Sci U S A,2002

5. Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research.;Klanova;Lab Invest,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robust and cost‐effective CRISPR/Cas9 gene editing of primary tumor B cells in Eµ‐TCL1 model of chronic lymphocytic leukemia;HemaSphere;2024-08

2. Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications;British Journal of Haematology;2024-06-21

3. ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV unmutated chronic lymphocytic leukemia;Blood Advances;2023-12-19